Reviewing Co-Diagnostics (NASDAQ:CODX) & AMN Healthcare Services (NYSE:AMN)

Co-Diagnostics (NASDAQ:CODX) and AMN Healthcare Services (NYSE:AMN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.

Analyst Ratings

This is a summary of current recommendations and price targets for Co-Diagnostics and AMN Healthcare Services, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Co-Diagnostics	1	1	1	1	2.50
AMN Healthcare Services	3	1	4	0	2.13

Co-Diagnostics presently has a consensus target price of $2.00, suggesting a potential upside of 469.80%. AMN Healthcare Services has a consensus target price of $21.75, suggesting a potential upside of 36.89%. Given Co-Diagnostics’ stronger consensus rating and higher probable upside, analysts plainly believe Co-Diagnostics is more favorable than AMN Healthcare Services.

Institutional & Insider Ownership

15.0% of Co-Diagnostics shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 5.4% of Co-Diagnostics shares are owned by insiders. Comparatively, 0.9% of AMN Healthcare Services shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Co-Diagnostics and AMN Healthcare Services”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Co-Diagnostics	$3.91 million	5.47	-$37.64 million	($0.99)	-0.35
AMN Healthcare Services	$2.72 billion	0.22	-$146.98 million	($7.19)	-2.21

Co-Diagnostics has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Co-Diagnostics, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Co-Diagnostics has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500. Comparatively, AMN Healthcare Services has a beta of 0.19, suggesting that its share price is 81% less volatile than the S&P 500.

Profitability

This table compares Co-Diagnostics and AMN Healthcare Services’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Co-Diagnostics	-6,347.34%	-70.26%	-61.19%
AMN Healthcare Services	-10.75%	11.09%	3.34%

Summary

Co-Diagnostics beats AMN Healthcare Services on 9 of the 15 factors compared between the two stocks.

About Co-Diagnostics

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

About AMN Healthcare Services

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, labor disruption staffing, local staffing, international nurse and allied permanent placement, and allied staffing solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including AMN Healthcare, Nursefinders, HealthSource Global Staffing, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is headquartered in Dallas, Texas.